2 weeks Ago By ABMN Staff
Invesco Ltd. acquired a new stake in Alpha Teknova, Inc. ( NASDAQ:TKNO – Free Report ) in the 4th quarter, Holdings Channel reports.
The fund acquired 1,106,161 shares of the company’s stock, valued at approximately $9,236,000. Several other hedge funds have also recently made changes to their positions in the company. Geode Capital Management LLC lifted its holdings in shares of Alpha Teknova by 24.
4% in the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after buying an additional 36,914 shares during the period. Raymond James Financial Inc.
purchased a new position in shares of Alpha Teknova in the fourth quarter valued at approximately $716,000. State Street Corp grew its holdings in shares of Alpha Teknova by 249.3% during the third quarter.
State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after buying an additional 54,700 shares in the last quarter. Nkcfo LLC purchased a new position in Alpha Teknova in the 4th quarter worth approximately $501,000. Finally, Tradewinds LLC.
purchased a new stake in Alpha Teknova in the 4th quarter valued at $383,000. 13.81% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes Separately, Craig Hallum began coverage on Alpha Teknova in a report on Monday, February 10th. They set a “buy” rating and a $12.00 price target for the company.
Alpha Teknova Price Performance Shares of NASDAQ TKNO opened at $6.43 on Thursday. The company has a current ratio of 4.
73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.
The stock has a market cap of $343.60 million, a P/E ratio of -8.69 and a beta of 0.
54. Alpha Teknova, Inc. has a twelve month low of $1.
16 and a twelve month high of $10.37. The stock has a 50 day moving average of $5.
92 and a two-hundred day moving average of $7.05. Alpha Teknova ( NASDAQ:TKNO – Get Free Report ) last announced its quarterly earnings data on Tuesday, March 4th.
The company reported ($0.11) earnings per share (EPS) for the quarter. Alpha Teknova had a negative net margin of 87.
17% and a negative return on equity of 35.30%. The firm had revenue of $9.
27 million during the quarter, compared to analyst estimates of $9.10 million. On average, research analysts forecast that Alpha Teknova, Inc.
will post -0.58 earnings per share for the current year. Alpha Teknova Profile ( Free Report ) Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Recommended Stories Want to see what other hedge funds are holding TKNO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alpha Teknova, Inc.
( NASDAQ:TKNO – Free Report ). Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter .
.
